Important Notice Regarding Alleged Anti-Monopoly Risk Misrepresentations Important Notice Regarding Alleged Anti-Monopoly Risk Misrepresentations

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered losses in Gemini Space Station, Inc. (NASDAQ: GEMI) to contact the firm. Those who purchased GEMI securities between September 12, 2025 and February 17, 2026 may be entitled to recover damages.

Promise vs. Reality: The NuScale Power ENTRA1 Partnership Performance Gap Promise vs. Reality: The NuScale Power ENTRA1 Partnership Performance Gap

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Medpace Holdings, Inc. ("Medpace Holdings, Inc." or the "Company") (NASDAQ: MEDP) of a class action securities lawsuit.

Kymera Therapeutics remains a "Strong Buy", driven by positive phase 1b data for KT-621 in atopic dermatitis and pipeline expansion. KT-621 achieved a mean 63% EASI reduction and 40% pruritus NRS reduction, supporting advancement into phase 2b BROADEN2 [AD] and BREADTH [asthma] trials. Both AD and asthma programs received FDA Fast Track Designation, with mid-2027 [BROADEN2] and late-2027 [BREADTH] data readouts as key milestones.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP examines the adequacy of Snowflake Inc.'s (NYSE: SNOW) risk disclosures during the period June 27, 2023 through February 28, 2024. A securities class action has been filed in the U.S. District Court for the Northern District of California on behalf of investors who purchased SNOW stock during that period and lost money.

Gladstone Capital (NASDAQ:GLAD) does not behave like a typical business development company.

IBM entered into a $17 million settlement agreement on Friday with the U.S. DOJ over allegations that it engaged in “illegal DEI practices” by taking into account “race, color, national origin, or sex” in its hiring and promotions. The DOJ also alleged that IBM used funds from its government contract for DEI programs and then sought reimbursement.

Important Information Regarding Section 20(a) Individual Liability Claims Important Information Regarding Section 20(a) Individual Liability Claims

Improved pricing, increasing climate-related risks and rapid digital transformation are set to influence the insurance industry's outlook in 2026. Although insurers remain exposed to catastrophe losses driven by climate change, stronger pricing continues to support profitability.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in uniQure N.V. ("uniQure" or the "Company") (NASDAQ: QURE) of a class action securities lawsuit.

New York, New York--(Newsfile Corp. - April 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Trip.com Group Limited (NASDAQ: TCOM) between April 30, 2024 and January 13, 2026, both dates inclusive (the "Class Period"), of the important May 11, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Trip.com securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the period March 26, 2025 through November 4, 2025 may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Stellantis N.V. ("Stellantis N.V." or the "Company") (NYSE: STLA) of a class action securities lawsuit.

The UK's antitrust authority has taken its first step towards launching a formal investigation into the $110B merger between Paramount and Warner Bros. Discovery. The Competition and Markets Authority said it was seeking comments from interested parties ahead of commencing a deeper examination of a deal that will reshape the global media landscape.

New York, New York--(Newsfile Corp. - April 13, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) between November 3, 2023 and March 16, 2026, both dates inclusive (the "Class Period"), of the important May 29, 2026 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Aldeyra securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

PITTSBURGH, April 13, 2026 /PRNewswire/ -- Howmet Aerospace Inc. (NYSE:HWM) announced today that Jonathan Arena has joined Howmet as Executive Vice President, Chief Legal and Compliance Officer and Secretary. He will also serve on the Howmet Aerospace Executive Leadership Team, the senior leadership team that sets strategic direction for the company.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP encourages investors who suffered losses in REGENXBIO, Inc. (NASDAQ: RGNX) to contact the firm. Those who purchased RGNX securities between February 9, 2022 and January 27, 2026 may be entitled to recover damages.

NEW YORK, April 13, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Boston Scientific Corporation (NYSE: BSX) during the period from July 23, 2025, through February 3, 2026, may wish to evaluate lead plaintiff opportunities in a pending securities class action. Request an institutional investor loss assessment.

The most attention-grabbing move was Berkshire's first-ever stake in the New York Times (NYSE:NYT).